ESTRO 2024 - Abstract Book

S1165

Clinical - Haematology

ESTRO 2024

Conclusion:

TSEBT is an effective treatment modality for both early and advanced stages. TSEBT provides excellent cutaneous responses and good long-term survival rates mainly in stages I-III with acceptable acute and chronic toxicity in patients with MF/SS.

Keywords: Mycosis fungoides,total skin electron-beam therapy

References:

1. Elsayad K, Susek KH, Eich HT. Total Skin Electron Beam Therapy as Part of Multimodal Treatment Strategies for Primary Cutaneous T-Cell Lymphoma. Oncol Res Treat. 2017;40(5):244-252

2. Yonekura K. Current treatment strategies and emerging therapies for cutaneous lymphoma. J Dermatol. 2022 Feb;49(2):223-231. doi: 10.1111/1346-8138.16289. Epub 2021 Dec 27. PMID: 34958516.

3. Ollila TA, Sahin I, Olszewski AJ. Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma. Onco Targets Ther. 2019 Feb 7;12:1085-1094.

4. Hristov AC, Tejasvi T, Wilcox RA. Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk stratification, and management. Am J Hematol. 2019 Sep;94(9):1027-1041.

1994

Digital Poster